Table 1 Pharmacotherapeutic groups considered for the IMA intervention, following the ATC Classification System [69]
A10 - Drugs used in diabetes | A10A - Insulins and analogues | A10AB - Insulins and analogues for injection, fast-acting |
A10AC - Insulins and analogues for injection, intermediate-acting | ||
A10AD - Insulins and analogues for injection, intermediate- or long-acting combined with fast-acting | ||
A10AE - Insulins and analogues for injection, long-acting | ||
A10B - Blood glucose lowering drugs, excluding insulins | A10BA - Biguanides | |
A10BB - Sulfonylureas | ||
A10BD - Combinations of oral blood glucose-lowering drugs | ||
A10BF - Alpha-glucosidase inhibitors | ||
A10BG - Thiazolidinediones | ||
A10BH - Dipeptidyl peptidase 4 (DPP-4) inhibitors | ||
A10BJ - Glucagon-like peptide-1 (GLP-1) analogues | ||
A10BK - Sodium-glucose co-transporter 2 (SGLT2) inhibitors | ||
A10BX - Other blood glucose-lowering drugs, excl. Insulins | ||
B01 - Antithrombotic agents | B01A - Antithrombotic agents | B01AC - Platelet aggregation inhibitors excl. Heparin |
C02 - Antihypertensives | C02A - Antiadrenergic agents, centrally acting | |
C02C - Antiadrenergic agents, peripherally acting | ||
C02D - Arteriolar smooth muscle, agents acting on | ||
C02K - Other Antihypertensives | ||
C03 - Diuretics | C03A - Low-ceiling diuretics, thiazides | |
C03B - Low-ceiling diuretics, excl. Thiazides | ||
C03C - High-ceiling diuretics | ||
C03D - Potassium-sparing agents | ||
C03E - Diuretics and potassium-sparing agents in combination | ||
C03X - Other diuretics | ||
C07 - Beta blocking agents | C07A - Beta blocking agents | |
C07B - Beta blocking agents and thiazides | ||
C07C - Beta blocking agents and other diuretics | ||
C07D - Beta blocking agents, thiazides and other diuretics | ||
C07F - Beta blocking agents, other combinations | ||
C08 - Calcium channel blockers | C08C - Selective calcium channel blockers with mainly vascular effects | |
C08D - Selective calcium channel blockers with direct cardiac effects | ||
C08G - Calcium channel blockers and diuretics | ||
C09 - Agents acting on the renin-angiotensin system | C09A - ACE inhibitors, plain | |
C09B - ACE inhibitors, combinations | ||
C09C - Angiotensin II receptor blockers (ARBS), plain | ||
C09D - Angiotensin II receptor blockers (ARBS), combinations | ||
C09X - Other agents acting on the renin-angiotensin system | ||
C10 - Lipid modifying agents | C10A - Lipid modifying agents, plain | C10AA - HMG coa reductase inhibitors |
C10AB - Fibrates | ||
C10AC - Bile acid sequestrants | ||
C10AD - Nicotinic acid and derivatives | ||
C10AX - Other lipid modifying agents | ||
C10B - Lipid modifying agents, combinations | C10BA - Combinations of various lipid modifying agents | |
C10BX - Lipid modifying agents in combination with other drugs |